Compare Otis Worldwide Corp (OTIS) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Otis Worldwide Corp vs Tenet Healthcare Corporation — how do they compare? Otis Worldwide Corp trades at $66.12 (market cap $25.03B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Otis Worldwide Corp is the larger of the two by market cap, and Otis Worldwide Corp pays a 2.68% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Otis Worldwide Corp for 65 Days and Tenet Healthcare Corporation for 15 Days on average.
| OTIS | THC | |
|---|---|---|
Market Cap | $25.03B | $20.92B |
Volume | 2,974,901 | 455,764 |
Sector | Industrials | Health |
52-Week High | $93.62 | $280.77 |
52-Week Low | $64.05 | $161.37 |
Typical Hold Time | 65 Days | 15 Days |
Enterprise Value | $33.06B | $32.00B |
Dividend Yield | 2.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Otis Worldwide trades at $66.11, down 0.51% on the day and near its 52-week low. The stock shows bearish technical signals with mixed analyst sentiment (46.7% buy, 46.7% hold). Recent earnings have missed expectations for three consecutive quarters, though the company maintains stable revenue around $14.4 billion and strong service-based cash flows. CEO succession plans for 2027 and margin pressures in China remain key focus areas.
The investment outlook balances Otis's market leadership in elevator services against near-term headwinds. Upside potential exists if service margins recover and China demand stabilizes, supported by a consensus price target of $87.00. However, risks include persistent cost pressures, weak equipment demand, and high debt levels with a debt-to-asset ratio of 75.54% in 2025.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
